A Phase III, Multicentre, Randomised, Double-Blind Study to Assess the Safety and Efficacy of Emactuzumab vs. Placebo in Subjects with Tenosynovial Giant Cell Tumour

Brief Summary

Type:
Sarcomas

Study Type:
Treatment

Phase:
III

ClinicalTrials.gov Identifier:
NCT05417789

Study #:
STUDY00160928

Start Date:
Mar 07, 2025

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT05417789

View Complete Trial Details & Eligibility at ClinicalTrials.gov